Tag Archives: funding

CHI Program to Offer Tips for Acquiring Pipeline Funding

AB23475

Biomedical innovations rely largely on scientific breakthroughs, which in turn happen through well-structured research programs. CHI’s Pipeline for Life  will focus on what characterizes successful basic research models in the 21st century, during a time when researchers are experiencing declining governmental funding for science research. Collaboration between industry and academic partners will be necessary to keep the biomedical ecosystem healthy, and the industry’s pipeline full of innovation. This half-day program will explore the strategies and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Crowdfunding Goes Viral

Crowdfunding

Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are a startup biotech company that raised $351,193. They asked for $100,000. That’s right; over three times their goal. “[Crowdfunding for biotech] is an idea whose time has come,” says μBiome’s CEO Jessica Richman. “The fact that we did it is proof of that. We’re the first ones but there will be lots of others.” Is there a way that crowdfunding could help Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Michael J. Fox Foundation Launches New Funding Opportunities

Parkinson's Disease

The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development with researchers from academia and industry alike in order to keep promising research moving forward along the Parkinson’s disease (PD) drug pipeline. To date, MJFF has funded over $300 million in research, $83 million of which has been awarded to more than 180 unique, industry-led projects. On February 20, MJFF launched nine funding programs, three of which are new to Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

California Biomedical Companies Cite Lack Of Funding As Major Concern

Investment

As I have mentioned in past blog posts, the U.S. bioscience industry has demonstrated stability through turbulent economic times. While not immune from the recession, this industry generally fared much better than the overall economy and has remained a net a job generator. In April of 2012, the White House released the National Bioeconomy Blueprint noting that bioscience industries are “a large and rapidly growing segment of the world economy that provides substantial public benefit.” Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Raising the Stakes in Biotech

JimGreenwood

Small biotech companies continue to struggle to obtain funding as capital markets remain tight. The S&P downgrade may create even tighter credit markets and raise the cost of available credit, for small and large companies. To the extent that the downgrade leads capital flows out of the U.S., that hurts biotech. Biotech’s contributions to the world are critically needed. Our industry holds great promise for curing and treating many prevalent diseases, such as Alzheimer’s, cancer, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,